fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Kidney Diseases in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (60.00) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altuntas, TG; Kharasch, ED; Zager, RA | 1 |
| Altuntas, TG; Kharasch, ED; Liggitt, HD; Schroeder, JL; Sheffels, P | 1 |
| Kharasch, ED; Liggitt, HD; Schroeder, JL; Sheffels, P | 1 |
| Bammler, T; Beyer, R; Kharasch, ED; Schroeder, JL; Srinouanprachanh, S | 1 |
| Eger, EI; Kandel, L; Kerschmann, RL; Laster, MJ; Martin, J | 1 |
| Eger, EI; Ferrell, LD; Gonsowski, CT; Kerschmann, RL; Laster, MJ | 2 |
| Callan, C; Cusick, PK; Delgado-Herrera, L; Friedman, MB; Hoffman, GM; Keller, KA; Krasula, RW; Prokocimer, P; Wooding, WL | 1 |
| Eger, EI; Kandel, L; Kerschmann, RL; Laster, MJ; Martin, JL; Reed, GF | 1 |
| Bowland, T; Eger, EI; Gong, D; Ionescu, P; Koblin, DD; Laster, MJ; Weiskopf, RB | 1 |
| Eger, EI; Gong, D; Ionescu, P; Kerschmann, RL; Laster, MJ; Weiskopf, RB | 1 |
| Ebert, TJ; Frink, EJ; Kharasch, ED | 1 |
| Anders, MW; Baggs, RB; Iyer, RA; Uttamsingh, V | 1 |
| Eger, EI | 1 |
| Gentz, BA; Malan, TP | 1 |
1 review(s) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Kidney Diseases
| Article | Year |
|---|---|
Renal toxicity with sevoflurane: a storm in a teacup?
Topics: Air Movements; Anesthetics, Inhalation; Drug Interactions; Ethers; Gases; Humans; Hydrocarbons, Fluorinated; Kidney; Kidney Diseases; Methyl Ethers; Sevoflurane | 2001 |
14 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Kidney Diseases
| Article | Year |
|---|---|
Cytotoxicity of S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl) vinyl ether (Compound A) in a human proximal tubular cell line.
Topics: Anesthetics, Inhalation; Cell Line; Cysteine; Ethers; Formazans; Glutathione; Humans; Hydrocarbons, Fluorinated; Kidney Diseases; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Methyl Ethers; Sevoflurane; Tetrazolium Salts | 2003 |
Role of cytochrome P4503A in cysteine S-conjugates sulfoxidation and the nephrotoxicity of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats.
Topics: Anesthetics, Inhalation; Animals; Aryl Hydrocarbon Hydroxylases; Cysteine; Cytochrome P-450 CYP3A; Dexamethasone; Ethers; Hydrocarbons, Fluorinated; Kidney Diseases; Lyases; Male; Methyl Ethers; Oxidoreductases, N-Demethylating; Phenobarbital; Propionates; Rats; Rats, Inbred F344; Sevoflurane; Sulfoxides; Troleandomycin | 2004 |
Influence of sevoflurane on the metabolism and renal effects of compound A in rats.
Topics: Anesthetics, Inhalation; Animals; Biotransformation; Ethers; Hydrocarbons, Fluorinated; Kidney; Kidney Diseases; Kidney Function Tests; Male; Methyl Ethers; Rats; Rats, Inbred F344; Sevoflurane; Sulfoxides | 2005 |
Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether ("compound A") in rats.
Topics: Anesthetics, Inhalation; Animals; Ethers; Gene Expression Profiling; Hydrocarbons, Fluorinated; Kidney; Kidney Diseases; Male; Methyl Ethers; Oligonucleotide Array Sequence Analysis; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sevoflurane | 2006 |
Nephrotoxicity in rats undergoing a one-hour exposure to compound A.
Topics: Animals; Cell Division; Cell Nucleus; Dose-Response Relationship, Drug; Ethers; Hydrocarbons, Fluorinated; Immunohistochemistry; Kidney Diseases; Liver; Male; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Vinyl Compounds | 1995 |
Toxicity of compound A in rats. Effect of increasing duration of administration.
Topics: Anesthetics; Animals; Body Weight; Cell Division; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethers; Hydrocarbons, Fluorinated; Immunohistochemistry; Kidney Diseases; Lethal Dose 50; Lung Diseases; Male; Methyl Ethers; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Pulmonary Edema; Rats; Rats, Wistar; Regeneration; Sevoflurane; Time Factors | 1994 |
Toxicity of compound A in rats. Effect of a 3-hour administration.
Topics: Anesthetics; Animals; Brain; Brain Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethers; Hydrocarbons, Fluorinated; Kidney Diseases; Lethal Dose 50; Male; Methyl Ethers; Rats; Rats, Wistar; Sevoflurane; Time Factors | 1994 |
Inhalation toxicity study of a haloalkene degradant of sevoflurane, Compound A (PIFE), in Sprague-Dawley rats.
Topics: Anesthetics, Inhalation; Animals; Blood Chemical Analysis; Blood Coagulation; Dose-Response Relationship, Drug; Ethers; Female; Hydrocarbons, Fluorinated; Kidney Diseases; Male; Methyl Ethers; Nasal Mucosa; Rats; Rats, Sprague-Dawley; Sevoflurane | 1995 |
Metabolism of compound A by renal cysteine-S-conjugate beta-lyase is not the mechanism of compound A-induced renal injury in the rat.
Topics: Aminooxyacetic Acid; Anesthetics, Inhalation; Animals; Buthionine Sulfoximine; Carbon-Sulfur Lyases; Enzyme Inhibitors; Ethers; Glutathione; Hydrocarbons, Fluorinated; Isoxazoles; Kidney; Kidney Diseases; Lyases; Male; Methionine Sulfoximine; Methyl Ethers; Rats; Rats, Wistar; Sevoflurane | 1996 |
Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers.
Topics: Adult; Anesthesia, General; Anesthetics, Inhalation; Biomarkers; Chemical and Drug Induced Liver Injury; Desflurane; Dose-Response Relationship, Drug; Ethers; Fluorides; Humans; Hydrocarbons, Fluorinated; Isoflurane; Kidney Diseases; Kidney Glomerulus; Liver Diseases; Male; Methyl Ethers; Sevoflurane; Temperature; Tidal Volume | 1997 |
Quantitative differences in the production and toxicity of CF2=BrCl versus CH2F-O-C(=CF2)(CF3) (compound A): the safety of halothane does not indicate the safety of sevoflurane.
Topics: Absorption; Aminooxyacetic Acid; Anesthetics, Inhalation; Animals; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Ethers; Halothane; Humans; Hydrocarbons, Fluorinated; Hydrocarbons, Halogenated; Isoxazoles; Kidney Diseases; Lyases; Methyl Ethers; Rats; Rats, Inbred F344; Rats, Wistar; Sevoflurane | 1997 |
Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers.
Topics: Adult; Alanine Transaminase; Anesthetics, Inhalation; Body Temperature; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Ethers; Glutathione Transferase; Glycosuria; Humans; Hydrocarbons, Fluorinated; Kidney; Kidney Diseases; Liver; Methyl Ethers; Proteinuria; Sevoflurane; Volunteers | 1998 |
Fate and toxicity of 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound A)-derived mercapturates in male, Fischer 344 rats.
Topics: Acetylcysteine; Acyltransferases; Anesthetics, Inhalation; Animals; Biotransformation; Chemical and Drug Induced Liver Injury; Cytosol; Dealkylation; Drug Contamination; Ethers; Hydrocarbons, Fluorinated; Kidney Diseases; Magnetic Resonance Spectroscopy; Male; Methyl Ethers; Rats; Rats, Inbred F344; Sevoflurane | 1998 |
Compound A: does it matter?
Topics: Adsorption; Anesthetics, Inhalation; Canada; Carbon Dioxide; Ethers; Humans; Hydrocarbons, Fluorinated; Kidney Diseases; Methyl Ethers; Sevoflurane | 2001 |